ClinicalTrials.Veeva

Menu
P

Perinatal HIV Research Unit (PHRU) | Soweto ACTG CRS

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

tenofovir disoproxil fumarate
Efavirenz
Emtricitabine
Raltegravir
Isoniazid
pyrazinamide
Delamanid
Atripla
/lamivudine
DLM

Parent organization

This site is a part of Perinatal HIV Research Unit (PHRU)

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 14 total trials

Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients (PHOENIx MDR-TB)

The purpose of this study is to compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing conf...

Enrolling
Tuberculosis, MDR
Dietary Supplement: Pyridoxine (vitamin B6)
Drug: Delamanid (DLM)

Trial sponsors

A
National Institute of Allergy and Infectious Diseases (NIAID) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems